BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4550511)

  • 1. Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):78-82. PubMed ID: 4550511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).
    Gerber P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):83-5. PubMed ID: 4550512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of spontaneous Epstein-Barr virus activation and selective DNA synthesis in activated cells in the presence of hydroxyurea.
    Hampar B; Derge JG; Martos LM; Tagamets MA; Burroughs MA
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2589-93. PubMed ID: 4341700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 6. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt lymphoblasts and their Epstein-Barr virus. Synthesis of viral DNA and proteins in arginine deprived cells.
    Becker Y; Weinberg A
    Isr J Med Sci; 1971 Apr; 7(4):561-7. PubMed ID: 4325616
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
    Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
    Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.
    Sugawara K; Osato T
    Nat New Biol; 1973 Jun; 243(128):209-10. PubMed ID: 4351756
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
    Miller G; Shope T; Lisco H; Stitt D; Lipman M
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):383-7. PubMed ID: 4333982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.
    Nyormoi O; Thorley-Lawson DA; Elkington J; Strominger JL
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1745-8. PubMed ID: 179098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus: stimulation by 5'-iododeoxyuridine or 5'-bromodeoxyuridine in human lymphoblastoid cells from a rhabdomyosarcoma.
    Houts GE; Szakacs MR; Szakacs JE
    Ann Clin Lab Sci; 1973; 3(6):429-33. PubMed ID: 4356930
    [No Abstract]   [Full Text] [Related]  

  • 14. Replication of latent Epstein-Barr virus genomes in normal and malignant lymphoid cells.
    Adams A; Pozos TC; Purvey HV
    Int J Cancer; 1989 Sep; 44(3):560-4. PubMed ID: 2550376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection.
    Nonoyama M; Pagano JS
    J Virol; 1972 Apr; 9(4):714-6. PubMed ID: 4336566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of latent Epstein-Barr virus genomes in Raji cells.
    Adams A
    J Virol; 1987 May; 61(5):1743-6. PubMed ID: 3033303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in thymidine kinase-inducing ability of herpesvirus types 1 and 2.
    Lowry SP; Bresnick E; Rawls WE
    Virology; 1971 Dec; 46(3):958-61. PubMed ID: 5002940
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on several parameters of Epstein-Barr virus infection.
    Zhang ZX; Liu YX; Chen HC; Allaudeen HS; De Clercq E
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():37-46. PubMed ID: 6319572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity.
    Ooka T; Calender A; de Turenne M; Daillie J
    J Virol; 1983 Apr; 46(1):187-95. PubMed ID: 6298456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines.
    zur Hansen H; Diehl V; Wolf H; Schulte-Holthausen H; Schneider U
    Nat New Biol; 1972 Jun; 237(75):189-90. PubMed ID: 4338521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.